本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ASLAN PHARMACEUTICALS LIMITED SPON ADS EACH REP 25 ORD SHS (P/S)

0.6000
+0.0000
成交量:- -
成交额:- -
市值:169.70万
市盈率:-0.04
高:0.6000
开:0.6000
低:0.6000
收:0.6000
数据加载中...
2019/11/07

SEC问询函

[Cover]Correspondence
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/17

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/06/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/31

招股说明书

Registration statement for certain foreign private issuers
2019/04/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]